The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
Open Access
- 1 January 2022
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Gastroenterology Review
- Vol. 17 (1) , 28-34
Abstract
Introduction The aim of the study was to assess the effectiveness of a patented preparation of sodium butyrate in the triglyceride matrix at reducing clinical symptoms and improving quality of life in patients with irritable bowel syndrome (IBS). Material and methods In this prospective...Keywords
This publication has 12 references indexed in Scilit:
- How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological FactorsAmerican Journal of Gastroenterology, 2018
- Sodium Butyrate Attenuates Diarrhea in Weaned Piglets and Promotes Tight Junction Protein Expression in Colon in a GPR109A-Dependent MannerCellular Physiology and Biochemistry, 2018
- Diet-Derived Short Chain Fatty Acids Stimulate Intestinal Epithelial Cells To Induce Mucosal Tolerogenic Dendritic CellsThe Journal of Immunology, 2017
- Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IVGastroenterology, 2016
- Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndromeColorectal Disease, 2013
- The epigenetic effects of butyrate: potential therapeutic implications for clinical practiceClinical Epigenetics, 2012
- Cecal Infusion of Butyrate Increases Intestinal Cell Proliferation in PigletsThe Journal of Nutrition, 2007
- Physiological and Anti‐Inflammatory Roles of Dietary Fiber and Butyrate in Intestinal FunctionsJournal of Parenteral and Enteral Nutrition, 1999
- Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis.Gut, 1994
- Butyrate production from dietary fibre and protection against large bowel cancer in a rat model.Gut, 1993